Secretariat invites comments on draft review of specific exemption for perfluorooctyl iodide (PFOI) used to produce perfluorooctyl bromide (PFOB) for pharmaceuticals

The Stockholm Convention Secretariat issued a communication inviting Parties and observers to submit comments on a draft report reviewing the specific exemption covering the use of perfluorooctyl iodide (PFOI) for the production of perfluorooctyl bromide (PFOB) for the purpose of producing pharmaceutical products. The communication sets a comment deadline of 22 May 2026. Compliance teams supporting pharmaceutical supply chains and Parties relying on this exemption should monitor the review outcome, as it may lead to changes to the scope, conditions, or continuation/expiry of the exemption under the Convention’s register of specific exemptions.